Accepted for Publication: March 25, 2012.
Published Online: May 21, 2012. doi:10.1001/archinternmed.2012.1796
Author Contributions: Drs Meier, Rizzoli, and Peter had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Meier, Stern, Rizzoli, and Peter. Acquisition of data: Meier and Peter. Analysis and interpretation of data: Meier, Perneger, Rizzoli, and Peter. Drafting of the manuscript: Meier, Rizzoli, and Peter. Critical revision of the manuscript for important intellectual content: Meier, Perneger, Stern, Rizzoli, and Peter. Statistical analysis: Meier, Perneger, and Rizzoli. Administrative, technical, and material support: Meier and Peter. Study supervision: Stern, Rizzoli, and Peter.
Financial Disclosure: Dr Rizzoli has attended paid advisory boards and has received consultancy and lecturing fees from Servier, Novartis, Eli Lilly, Amgen, Roche, Nycomed, Merck Sharp and Dohme, Alken, and Danone.
Additional Contributions: Claire Durosier and Fanny Merminod collected data for controls; Anne Lübbeke-wolff, Thierry Chevalley, and Kuntheavy Ing-Lorenzini provided helpful discussions; and René Bourdilloud, Gilles Cohen, and Jean-Jacques Chale provided technical assistance with the Medical and Economic Analysis Database of the University Hospitals of Geneva.